Sfoglia per Autore
A 41-Gene Signature Predicts Complete Response (CR) to Bortezomib-Thalidomide-Dexamethasone (VTD) As Induction Therapy Prior to Autologous Stem-Cell Transplantation (ASCT) in Multiple Myeloma (MM)
2011 Terragna, C ; Remondini, D; Durante, S; Martello, M; Patriarca, F; Levi, A; Pantani, L; Donnarumma, D ; Crippa, C; Bringhen, S; Rambaldi, A ; Offidani, M; Corradini, P; Narni, F; Fioritoni, G; Zaccaria, A; Baldini, L; Caravita, T; La Nasa, G; Cortelazzo, S; Martinelli, G; Baccarani, M; Cavo, M
Overexpression of FBP1 is Associated to High Sokal Risk in Chronic Myeloid Leukemia Patients.
2011 Durante, S; Terragna, C; Astolfi, A; Palandri, F; Castagnetti, F; Testoni, N; Amabile, M; Iacobucci, I; Soverini, S; Alimena, G; Breccia, M; Pane, F; Saglio, G; Rosti, G; Baccarani, M; Martinelli, G
c-MYC oncoprotein dictates transcriptional profiles of ATP-binding cassette transporter genes in Chronic Myelogenous Leukemia CD34+ hematopoietic progenitor cells
2011 A. Porro; N. Iraci; S. Soverini; D. Diolaiti; S. Gherardi; C. Terragna; S. Durante; E. Valli; T. Kalebic; R. Bernardoni; C. Perrod; M. Haber; M.D. Norris; M. Baccarani; G. Martinelli; G. Perini
HIF 1 Alpha: A Suitable Target for Multiple Myeloma
2011 PERRONE G; BORSI E; TERRAGNA C; DURANTE S; MARTELLO M; ALUIGI M; MANCINI M; ZAMAGNI E; TACCHETTI P; BRIOLI A; PANTANI L; ZANNETTI BA; MARTINELLI G; SANTUCCI MA; BACCARANI M; CAVO M
Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation
2011 Zamagni E.; Patriarca F.; Nanni C.; Zannetti B.; Englaro E.; Pezzi A.; Tacchetti P.; Buttignol S.; Perrone G.; Brioli A.; Pantani L.; Terragna C.; Carobolante F.; Baccarani M.; Fanin R.; Fanti S.; Cavo M.
PF-04449913 Reverts Multi Drug Resistance (MDR) by a Strong Down-Regulation of ABCA2 and BCL2 on Leukemia Stem Cells in Phase I Acute Myeloid Leukemia and Chronic Myeloid Leukemia Treated Patients
2011 Cristina Papayannidis, Viviana Guadagnuolo, Ilaria Iacobucci, Sandra Durante, Carolina Terragna, Emanuela Ottaviani, Maria Chiara Abbenante, Federica Cattina, Simona Soverini, Barbara Lama, Lucia Toni, Wendy J. Levin, Rachel Courtney, Carmen Baldazzi, Antonio Curti, Michele Baccarani, Catriona Jamieson, Jorge E. Cortes, Vivian Oehler, Karen McLachlan, Todd Van Arsdale, Giovanni Martinelli
High Number of Copy Number Alterations and Over-Expression of Genes Involved in the Response Mechanisms to Genotoxic Stress Both Characterize Newly Diagnosed Multiple Myeloma (MM) Patients Carrying Amplified MDM4 and/or Deleted p53
2011 TERRAGNA C; MARTELLO M; DURANTE S; PANTANI L; ZAMAGNI E; TACCHETTI P; BRIOLI A; PERRONE G; ZANNETTI BA; BORSI E; BACCARANI M; MARTINELLI G; CAVO M
GAS1 AND KIF27 GENES ARE STRONGLY UP-REGULATED BIOMARKERS OF HEDGEHOG INHIBITION (PF-04449913) ON LEUKEMIA STEM CELLS IN PHASE I ACUTE MYELOID LEUKEMIA AND CHRONIC MYELOID LEUKEMIA TREATED PATIENTS
2012 V Guadagnuolo; C Papayannidis; I Iacobucci; S Durante; C Terragna; E Ottaviani; F Cattina; M Abbenante; S Soverini; L Toni; W Levin; R Courtney; C Baldazzi; A Curti; M Baccarani; C Jamieson; J Cortes; V Oehler; K McLachlan; T Van Arsdale; G Martinelli
HIF-1a INHIBITION PROMOTES CELL CYCLE ARREST IN MULTIPLE MYELOMA
2012 G Perrone; E Borsi; C Terragna; M Martello; M Mancini; M Aluigi; MA Santucci; G Martinelli; M Baccarani; M Cavo
Gas1 and Kif27 genes are strongly up-regulated biomarkers of Hedgehog inhibition (PF-04449913) on leukemia stem cells in Phase I Acute Myeloid Leukemia and Chronic Myeloid Leukemia treated patients
2012 Viviana Guadagnuolo; Cristina Papayannidis; Ilaria Iacobucci; Sandra Durante; Carolina Terragna; Emanuela Ottaviani; Maria Chiara Abbenante; Federica Cattina; Simona Soverini; Barbara Lama; Lucia Toni; Wendy Levin; Rachel Courtney; Carmen Baldazzi; Antonio Curti; Michele Baccarani; Catriona Jamieson; Jorge Cortes; Vivian Oehler; Karen McLachlan; Todd VanArsdale; Giovanni Martinelli
High CNA level and over-expression of genes involved in response mechanisms to genotoxic stress characterize newly diagnosed Multiple Myeloma (MM) patients carrying amplified MDM4 and/or deleted TP53
2012 Terragna C; Martello M; Pantani L; Patriarca F; Zamagni E; Galli M; Tacchetti P; Petrucci MT; Crippa C; Bringhen S; Brioli A; Offidani M; Perrone G; Zannetti BA; Borsi E; Testoni N; Marzocchi G; Baccarani M; Martinelli G; Cavo M.
PF-04449913 reverts multi drug resistance (MDR) by a strong down-regulation of ABCA2 and BCL2 on leukemia stem cells in phase I acute myeloid leukemia and chronic myeloid leukemia treated patients
2012 Papayannidis C; Guadagnuolo V; Iacobucci I; Durante S; Terragna C; Ottaviani E; Abbenante MC; Cattina F; Soverini S; Lama B; Toni L; Levin W; Courtney R; Baldazzi C; Curti A; Baccarani M; Jamieson C; Cortes J; Oehler V; McLachlan K; VanArsdale T; Martinelli G.
Impact of Bortezomib Incorporated Into Autotransplantation On Outcomes of Myeloma Patients with High-Risk Cytogenetics: An Integrated Analysis of 1894 Patients Enrolled in Four European Phase 3 Studies
2012 Cavo, M; Sonneveld, P; Moreau, P; Blade, J; Goldschmidt, H; San Miguel, JF; Attal, M; Avet-Loiseau, H; Blau, WI; Facon, T; Gutierrez, N; Harousseau, JL; van der Holt, B; Jose Lahuerta, J; Lokhorst, H; Marit, G; Luisa Martin, M; Marzocchi, G; Palumbo, A; Patriarca, F; Petrucci, MT; Rosinol, L; Salwender, H; Terragna, C
Gene expression analysis of newly diagnosed Multiple Myeloma (MM) patients carrying amplified MDM4 and/or deleted p5
2012 Terragna, C; Martello, M; Martinelli, G; Durante, S; Pantani, L; Zamagni, E; Tacchetti, P; Brioli, A; Perrone, G; Zannetti, Ba; Borsi, E; Biasco, G; Baccarani, M; Cavo, M.
Long-term results of thalidomide and dexamethasone (thal-dex) as therapy of first relapse in multiple myeloma.
2012 Zamagni E; Petrucci A; Tosi P; Tacchetti P; Perrone G; Brioli A; Pantani L; Zannetti B; Terragna C; Baccarani M; Cavo M.
Analysis of Bone Marrow Microenviroment Factors As Early Markers of Response in Patients with Newly Diagnosed Bcr-Abl Positive CML in Chronic Phase Treated with Nilotinib
2012 Concetta Quintarelli; Biagio De Angelis; Santa Errichiello; Simona Caruso; Nicola Esposito; Luigia Luciano; Simona Paratore; Claudia Galimberti; Simona Soverini; Carolina Terragna; Daniela Cilloni; Giuseppe Saglio; Giovanni Martinelli; Frank Giles; Andreas Hochhaus; Fabrizio Pane
A 41-gene signature predicts complete response (CR) to Bortezomib-Thalidomide-Dexamethasone (VTD) as induction therapy prior to autologous stem-cell transplantation (ASCT) in multiple myeloma (MM).
2013 Terragna, Carolina; Remondini, Daniel; Martello, Marina; Pezzi, Annalisa; Patriarca, Francesca; Levi, Anna; Pantani, Lucia; Donnarumma, Daniela; Montanaro, Lorenzo; Crippa, Claudia; Bringhen, Sarah; Rambaldi, Alessandro; Offidani, Massimo; Corradini, Paolo; Narni, Franco; Fioritoni, Giuseppe; Zaccaria, Alfonso; Baldini, Luca; Caravita, Tommaso; La Nasa, Giorgio; Cortellazzo, Sergio; Martinelli, Giovanni; Cavo, Michele
Genomic characterization of the putative myeloma stem cells clone reveals alterations possibly correlated with the origin of disease.
2013 Martello, M; Terragna, C; Martinelli, G; Borsi, E; Zamagni, E; Pantani, L; Tacchetti, P; Zannetti, B; Mancuso, K; Dico, F; Cavo, M
SIRT regulates the molecular interaction between c-MYC and HIF-1 alpha in multiple myeloma
2013 Borsi, E; Perrone, G; Terragna, C; Martello, M; Mancini, M; Leo, E; Zamagni, E; Tacchetti, P; Brioli, A; Pantani, L; Zannetti, B; Martinelli, G; Cavo, M
Impact Of p53 Impaired Function On Outcomes Of Multiple Myeloma Patients Carrying Deleted TP53 and/Or Amplified MDM4
2013 Terragna, Carolina; Martello, Marina; Borsi, Enrica; Pantani, Lucia; Zamagni, Elena; Tacchetti, Paola; Annamaria, Brioli; Zannetti, Beatrice Anna; Dico, Flores; Testoni, Nicoletta; Marzocchi, Giulia; Mancuso, Katia; Rocchi, Serena; Martinelli, Giovanni; Cavo, Michele
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| A 41-Gene Signature Predicts Complete Response (CR) to Bortezomib-Thalidomide-Dexamethasone (VTD) As Induction Therapy Prior to Autologous Stem-Cell Transplantation (ASCT) in Multiple Myeloma (MM) | Terragna, C ; Remondini, D; Durante, S; Martello, M; Patriarca, F; Levi, A; Pantani, L; Donnarumm...a, D ; Crippa, C; Bringhen, S; Rambaldi, A ; Offidani, M; Corradini, P; Narni, F; Fioritoni, G; Zaccaria, A; Baldini, L; Caravita, T; La Nasa, G; Cortelazzo, S; Martinelli, G; Baccarani, M; Cavo, M | 2011-01-01 | - | - | 4.02 Riassunto (Abstract) | - |
| Overexpression of FBP1 is Associated to High Sokal Risk in Chronic Myeloid Leukemia Patients. | Durante, S; Terragna, C; Astolfi, A; Palandri, F; Castagnetti, F; Testoni, N; Amabile, M; Iacobuc...ci, I; Soverini, S; Alimena, G; Breccia, M; Pane, F; Saglio, G; Rosti, G; Baccarani, M; Martinelli, G | 2011-01-01 | - | - | 4.02 Riassunto (Abstract) | - |
| c-MYC oncoprotein dictates transcriptional profiles of ATP-binding cassette transporter genes in Chronic Myelogenous Leukemia CD34+ hematopoietic progenitor cells | A. Porro; N. Iraci; S. Soverini; D. Diolaiti; S. Gherardi; C. Terragna; S. Durante; E. Valli; T. ...Kalebic; R. Bernardoni; C. Perrod; M. Haber; M.D. Norris; M. Baccarani; G. Martinelli; G. Perini | 2011-01-01 | MOLECULAR CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| HIF 1 Alpha: A Suitable Target for Multiple Myeloma | PERRONE G; BORSI E; TERRAGNA C; DURANTE S; MARTELLO M; ALUIGI M; MANCINI M; ZAMAGNI E; TACCHETTI ...P; BRIOLI A; PANTANI L; ZANNETTI BA; MARTINELLI G; SANTUCCI MA; BACCARANI M; CAVO M | 2011-01-01 | BLOOD | - | 4.02 Riassunto (Abstract) | - |
| Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation | Zamagni E.; Patriarca F.; Nanni C.; Zannetti B.; Englaro E.; Pezzi A.; Tacchetti P.; Buttignol S....; Perrone G.; Brioli A.; Pantani L.; Terragna C.; Carobolante F.; Baccarani M.; Fanin R.; Fanti S.; Cavo M. | 2011-01-01 | BLOOD | - | 1.01 Articolo in rivista | - |
| PF-04449913 Reverts Multi Drug Resistance (MDR) by a Strong Down-Regulation of ABCA2 and BCL2 on Leukemia Stem Cells in Phase I Acute Myeloid Leukemia and Chronic Myeloid Leukemia Treated Patients | Cristina Papayannidis, Viviana Guadagnuolo, Ilaria Iacobucci, Sandra Durante, Carolina Terragna, ...Emanuela Ottaviani, Maria Chiara Abbenante, Federica Cattina, Simona Soverini, Barbara Lama, Lucia Toni, Wendy J. Levin, Rachel Courtney, Carmen Baldazzi, Antonio Curti, Michele Baccarani, Catriona Jamieson, Jorge E. Cortes, Vivian Oehler, Karen McLachlan, Todd Van Arsdale, Giovanni Martinelli | 2011-01-01 | BLOOD | - | 1.06 Abstract in rivista | - |
| High Number of Copy Number Alterations and Over-Expression of Genes Involved in the Response Mechanisms to Genotoxic Stress Both Characterize Newly Diagnosed Multiple Myeloma (MM) Patients Carrying Amplified MDM4 and/or Deleted p53 | TERRAGNA C; MARTELLO M; DURANTE S; PANTANI L; ZAMAGNI E; TACCHETTI P; BRIOLI A; PERRONE G; ZANNET...TI BA; BORSI E; BACCARANI M; MARTINELLI G; CAVO M | 2011-01-01 | BLOOD | - | 4.02 Riassunto (Abstract) | - |
| GAS1 AND KIF27 GENES ARE STRONGLY UP-REGULATED BIOMARKERS OF HEDGEHOG INHIBITION (PF-04449913) ON LEUKEMIA STEM CELLS IN PHASE I ACUTE MYELOID LEUKEMIA AND CHRONIC MYELOID LEUKEMIA TREATED PATIENTS | V Guadagnuolo; C Papayannidis; I Iacobucci; S Durante; C Terragna; E Ottaviani; F Cattina; M Abbe...nante; S Soverini; L Toni; W Levin; R Courtney; C Baldazzi; A Curti; M Baccarani; C Jamieson; J Cortes; V Oehler; K McLachlan; T Van Arsdale; G Martinelli | 2012-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
| HIF-1a INHIBITION PROMOTES CELL CYCLE ARREST IN MULTIPLE MYELOMA | G Perrone; E Borsi; C Terragna; M Martello; M Mancini; M Aluigi; MA Santucci; G Martinelli; M Bac...carani; M Cavo | 2012-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
| Gas1 and Kif27 genes are strongly up-regulated biomarkers of Hedgehog inhibition (PF-04449913) on leukemia stem cells in Phase I Acute Myeloid Leukemia and Chronic Myeloid Leukemia treated patients | Viviana Guadagnuolo; Cristina Papayannidis; Ilaria Iacobucci; Sandra Durante; Carolina Terragna; ...Emanuela Ottaviani; Maria Chiara Abbenante; Federica Cattina; Simona Soverini; Barbara Lama; Lucia Toni; Wendy Levin; Rachel Courtney; Carmen Baldazzi; Antonio Curti; Michele Baccarani; Catriona Jamieson; Jorge Cortes; Vivian Oehler; Karen McLachlan; Todd VanArsdale; Giovanni Martinelli | 2012-01-01 | CANCER RESEARCH | - | 4.02 Riassunto (Abstract) | - |
| High CNA level and over-expression of genes involved in response mechanisms to genotoxic stress characterize newly diagnosed Multiple Myeloma (MM) patients carrying amplified MDM4 and/or deleted TP53 | Terragna C; Martello M; Pantani L; Patriarca F; Zamagni E; Galli M; Tacchetti P; Petrucci MT; Cri...ppa C; Bringhen S; Brioli A; Offidani M; Perrone G; Zannetti BA; Borsi E; Testoni N; Marzocchi G; Baccarani M; Martinelli G; Cavo M. | 2012-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
| PF-04449913 reverts multi drug resistance (MDR) by a strong down-regulation of ABCA2 and BCL2 on leukemia stem cells in phase I acute myeloid leukemia and chronic myeloid leukemia treated patients | Papayannidis C; Guadagnuolo V; Iacobucci I; Durante S; Terragna C; Ottaviani E; Abbenante MC; Cat...tina F; Soverini S; Lama B; Toni L; Levin W; Courtney R; Baldazzi C; Curti A; Baccarani M; Jamieson C; Cortes J; Oehler V; McLachlan K; VanArsdale T; Martinelli G. | 2012-01-01 | CANCER RESEARCH | - | 4.02 Riassunto (Abstract) | - |
| Impact of Bortezomib Incorporated Into Autotransplantation On Outcomes of Myeloma Patients with High-Risk Cytogenetics: An Integrated Analysis of 1894 Patients Enrolled in Four European Phase 3 Studies | Cavo, M; Sonneveld, P; Moreau, P; Blade, J; Goldschmidt, H; San Miguel, JF; Attal, M; Avet-Loisea...u, H; Blau, WI; Facon, T; Gutierrez, N; Harousseau, JL; van der Holt, B; Jose Lahuerta, J; Lokhorst, H; Marit, G; Luisa Martin, M; Marzocchi, G; Palumbo, A; Patriarca, F; Petrucci, MT; Rosinol, L; Salwender, H; Terragna, C | 2012-01-01 | - | - | 4.02 Riassunto (Abstract) | - |
| Gene expression analysis of newly diagnosed Multiple Myeloma (MM) patients carrying amplified MDM4 and/or deleted p5 | Terragna, C; Martello, M; Martinelli, G; Durante, S; Pantani, L; Zamagni, E; Tacchetti, P; Brioli..., A; Perrone, G; Zannetti, Ba; Borsi, E; Biasco, G; Baccarani, M; Cavo, M. | 2012-01-01 | CANCER RESEARCH | - | 4.02 Riassunto (Abstract) | - |
| Long-term results of thalidomide and dexamethasone (thal-dex) as therapy of first relapse in multiple myeloma. | Zamagni E; Petrucci A; Tosi P; Tacchetti P; Perrone G; Brioli A; Pantani L; Zannetti B; Terragna ...C; Baccarani M; Cavo M. | 2012-01-01 | ANNALS OF HEMATOLOGY | - | 1.01 Articolo in rivista | - |
| Analysis of Bone Marrow Microenviroment Factors As Early Markers of Response in Patients with Newly Diagnosed Bcr-Abl Positive CML in Chronic Phase Treated with Nilotinib | Concetta Quintarelli; Biagio De Angelis; Santa Errichiello; Simona Caruso; Nicola Esposito; Luigi...a Luciano; Simona Paratore; Claudia Galimberti; Simona Soverini; Carolina Terragna; Daniela Cilloni; Giuseppe Saglio; Giovanni Martinelli; Frank Giles; Andreas Hochhaus; Fabrizio Pane | 2012-01-01 | BLOOD | - | 4.02 Riassunto (Abstract) | - |
| A 41-gene signature predicts complete response (CR) to Bortezomib-Thalidomide-Dexamethasone (VTD) as induction therapy prior to autologous stem-cell transplantation (ASCT) in multiple myeloma (MM). | Terragna, Carolina; Remondini, Daniel; Martello, Marina; Pezzi, Annalisa; Patriarca, Francesca; L...evi, Anna; Pantani, Lucia; Donnarumma, Daniela; Montanaro, Lorenzo; Crippa, Claudia; Bringhen, Sarah; Rambaldi, Alessandro; Offidani, Massimo; Corradini, Paolo; Narni, Franco; Fioritoni, Giuseppe; Zaccaria, Alfonso; Baldini, Luca; Caravita, Tommaso; La Nasa, Giorgio; Cortellazzo, Sergio; Martinelli, Giovanni; Cavo, Michele | 2013-01-01 | - | - | 4.02 Riassunto (Abstract) | - |
| Genomic characterization of the putative myeloma stem cells clone reveals alterations possibly correlated with the origin of disease. | Martello, M; Terragna, C; Martinelli, G; Borsi, E; Zamagni, E; Pantani, L; Tacchetti, P; Zannetti..., B; Mancuso, K; Dico, F; Cavo, M | 2013-01-01 | - | - | 4.02 Riassunto (Abstract) | - |
| SIRT regulates the molecular interaction between c-MYC and HIF-1 alpha in multiple myeloma | Borsi, E; Perrone, G; Terragna, C; Martello, M; Mancini, M; Leo, E; Zamagni, E; Tacchetti, P; Bri...oli, A; Pantani, L; Zannetti, B; Martinelli, G; Cavo, M | 2013-01-01 | - | - | 4.02 Riassunto (Abstract) | - |
| Impact Of p53 Impaired Function On Outcomes Of Multiple Myeloma Patients Carrying Deleted TP53 and/Or Amplified MDM4 | Terragna, Carolina; Martello, Marina; Borsi, Enrica; Pantani, Lucia; Zamagni, Elena; Tacchetti, P...aola; Annamaria, Brioli; Zannetti, Beatrice Anna; Dico, Flores; Testoni, Nicoletta; Marzocchi, Giulia; Mancuso, Katia; Rocchi, Serena; Martinelli, Giovanni; Cavo, Michele | 2013-01-01 | - | - | 4.02 Riassunto (Abstract) | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile